Tokyo, Japan

Nobuhiro Nakamoto

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Keio University. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nobuhiro Nakamoto. Retrieved from https://idiyas.com/inventor/nobuhiro-nakamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Nobuhiro Nakamoto

Introduction

Nobuhiro Nakamoto is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical research, particularly in understanding liver inflammation. With a total of two patents to his name, his work has the potential to impact the treatment of liver-related diseases.

Latest Patents

Nakamoto's latest patents focus on strains inducing inflammation in the liver. One of his notable inventions aims to identify a microorganism responsible for the development of primary sclerosing cholangitis associated with ulcerative colitis. This research is crucial for advancing medical knowledge and treatment options for patients suffering from these conditions.

Career Highlights

Nobuhiro Nakamoto is affiliated with Keio University, where he conducts his research and develops his inventions. His academic background and ongoing research contribute to the advancement of medical science, particularly in the area of liver health.

Collaborations

Some of his notable coworkers include Nobuo Sasaki and Ryo Aoki. Their collaboration enhances the research environment and fosters innovation in their respective fields.

Conclusion

Nobuhiro Nakamoto's work exemplifies the importance of innovation in medical research. His patents and ongoing contributions are paving the way for new treatments and a better understanding of liver diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…